A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC
Clinical trial NCT04878016 · COMPLETED
Trial details
- NCT number
- NCT04878016
- Sponsor
- Lee's Pharmaceutical Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2023-10-13
- Enrollment
- 498
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.